News
Novo Nordisk offers lower Ozempic price for customers whose insurance does not cover costs
People who are prescribed Ozempic to treat type 2 diabetes, but whose insurance does not cover it, or who don’t have insurance, will be able to buy the medication at a lower cost. Novo Nordisk announced on Monday that it will offer Ozempic for $499 a month through the GoodRx platform.
Novo Nordisk Offers Ozempic at $499 Per Month to Eligible US Cash-Paying Customers
(Reuters) -Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients with type 2 diabetes in the U.S. via its own pharmacy, a tie-up with telehealth service GoodRx and other platforms.
Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through ...
GoodRx Holdings Inc. (NASDAQ:GDRX) announced that, via a collaboration with Novo Nordisk A/S (NYSE:NVO), all strengths of ...
Patients who are prescribed Wegovy or Ozempic can now use GoodRx to access the medications at just $499 a month if they skip ...
14hon MSN
Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients
Who benefits? The reduced price applies to self-paying patients—those without insurance, or whose insurance doesn’t cover ...
Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for ...
Novo Nordisk is slashing the cost of Ozempic for cash-paying patients after the diabetes shot became the poster child for ...
10hon MSN
Ozempic creator Novo Nordisk will sell weight loss drugs for cheaper through this new partnership
T elemedicine company GoodRx ( GDRX) has been helping Americans find the cheapest way to buy drugs for years. Thanks to a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback